Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1996
11/12/1996US5573909 Fluorescent labeling using microparticles with controllable stokes shift
11/12/1996US5573906 Detection of nucleic acids using a hairpin forming oligonucleotide primer and an energy transfer detection system
11/12/1996US5573905 Encoded combinatorial chemical libraries
11/12/1996US5573766 Application to plants, active against lepidoptera and coleoptera
11/12/1996US5573763 Family of CSF-l proteins
11/12/1996CA2068438C Essential pure human parathyroid hormone
11/12/1996CA1338708C Neisserial vaccines
11/12/1996CA1338707C Protein h being capable of binding to igg, gene coding for the said protein h and a process for producing the said protein h
11/12/1996CA1338706C Monoclonal anti-human breast cancer antibodies suitable for imaging breast cancer
11/12/1996CA1338705C Vaccines obtained from antigenic gene products of recombinant genes
11/07/1996WO1996035126A1 Assessing calcineurin's role in immunosuppression and neurotoxicity
11/07/1996WO1996034985A1 Assay and method for transcript imaging
11/07/1996WO1996034983A1 Methods and reagents for combined pcr amplification and hybridization probing assay
11/07/1996WO1996034981A2 METHOD FOR THE SPECIFIC COUPLING OF THE CAP OF THE EXTREMITY 5' OF A FRAGMENT mRNA AND PREPARATION OF mRNA AND COMPLETE cDNA
11/07/1996WO1996034980A1 Method for diagnosing schizophrenia
11/07/1996WO1996034976A1 Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity
11/07/1996WO1996034974A1 Low oxygen affinity mutant hemoglobin
11/07/1996WO1996034970A1 Improved methods for transfecting t cells
11/07/1996WO1996034969A2 Gene therapy using replication competent targeted adenoviral vectors
11/07/1996WO1996034968A2 Improvements in or relating to plant starch composition
11/07/1996WO1996034967A1 Apparatus and method for delivering a nucleotide into cell nuclei
11/07/1996WO1996034966A2 Engineering protein posttranslational modification in transgenic organisms
11/07/1996WO1996034965A2 Chimeric mcp and daf proteins with cell surface localizing domain
11/07/1996WO1996034964A2 Stable variant hk2 polypeptide
11/07/1996WO1996034963A1 Alkaline protease and process for its production
11/07/1996WO1996034962A1 Scytalidium catalase gene
11/07/1996WO1996034961A1 Application of glucose transport mutants for production of aromatic pathway compounds
11/07/1996WO1996034960A1 High molecular weight major outer membrane protein of moraxella
11/07/1996WO1996034959A1 Aluminium resistance gene
11/07/1996WO1996034958A1 Vasoactive intestinal peptide
11/07/1996WO1996034957A1 Pancreas-derived serpin
11/07/1996WO1996034956A1 Methods for modulating t cell survival by modulating bcl-xl protein level
11/07/1996WO1996034955A1 Method of treating cartilaginous diseases with genetically modified chondrocytes
11/07/1996WO1996034954A2 Biotin-binding containment systems
11/07/1996WO1996034953A2 Cd16-ii variants
11/07/1996WO1996034951A1 Gdu, a novel signalling protein
11/07/1996WO1996034950A1 E6ap antisense constructs and methods of use
11/07/1996WO1996034949A1 Plant promoter activated by fungal infection
11/07/1996WO1996034946A1 Protease variants and compositions
11/07/1996WO1996034940A1 Dna encoding glutamate gated chloride channels
11/07/1996WO1996034935A2 Subtilisin variants
11/07/1996WO1996034893A1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits
11/07/1996WO1996034892A1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034888A1 Modulation of cholesteryl ester transfer protein (cetp) activity
11/07/1996WO1996034885A2 Biologically active peptide fragments of ob protein
11/07/1996WO1996034882A1 Single chain insulin with high bioactivity
11/07/1996WO1996034880A1 Cd6 ligand
11/07/1996WO1996034879A1 Identification of enantiomeric ligands
11/07/1996WO1996034875A1 Systematic evolution of ligands by exponential enrichment: tissue selex
11/07/1996WO1996034874A1 Nucleic acid ligands of tissue target
11/07/1996WO1996034631A1 Method for introducing and expressing genes in animal cells
11/07/1996WO1996034627A1 Murine and human box-dependent myc-interacting protein (bin1) and uses therefor
11/07/1996WO1996034625A1 Recombinant vesiculoviruses and their uses
11/07/1996WO1996034622A1 Modified myelin protein molecules
11/07/1996WO1996031610A3 Exopolysaccharide degrading enzyme and use of the same
11/07/1996WO1996031609A3 Transgenic plants expressing acetyl coa carboxylase gene
11/07/1996WO1996030520A3 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
11/07/1996WO1996030493A3 Promoters derived from acc oxidase genes
11/07/1996WO1996029409A3 Rage tumor rejection antigens
11/07/1996WO1996027664A3 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
11/07/1996WO1996025507A3 Methods of preparation and use of recombinant adenoviral vectors
11/07/1996WO1996022379A3 Direct gene transfer into the ruminant mammary gland
11/07/1996WO1996015241A3 A polynucleotide tuberculosis vaccine
11/07/1996CA2645735A1 Systematic evolution of ligands by exponential enrichment: tissue selex
11/07/1996CA2641149A1 Nucleic acid ligands of tissue target
11/07/1996CA2223272A1 Single chain insulin with high bioactivity
11/07/1996CA2220333A1 Plant promoter activated by fungal infection
11/07/1996CA2220300A1 Assay and method for transcript imaging
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2220109A1 Engineering protein posttranslational modification in transgenic organisms
11/07/1996CA2220098A1 Cd6 ligand
11/07/1996CA2220016A1 Gdu, a novel signalling protein
11/07/1996CA2219994A1 Method for introducing and expressing genes in animal cells
11/07/1996CA2219949A1 Protease variants and compositions
11/07/1996CA2219936A1 Vasoactive intestinal peptide
11/07/1996CA2219889A1 High molecular weight major outer membrane protein of moraxella
11/07/1996CA2219775A1 Murine and human box-dependent myc-interacting protein (bin1) and uses therefor
11/07/1996CA2219091A1 Apparatus and method for delivering a nucleotide into cell nuclei
11/07/1996CA2218858A1 Modified myelin protein molecules
11/07/1996CA2218390A1 Gene therapy using replication competent targeted adenoviral vectors
11/07/1996CA2218083A1 Identification of enantiomeric ligands
11/07/1996CA2218034A1 Pancreas-derived serpin
11/07/1996CA2217878A1 Improvements in or relating to plant starch composition
11/07/1996CA2217332A1 Method for diagnosing schizophrenia
11/07/1996CA2217162A1 Subtilisin variants
11/06/1996EP0741189A1 Process for producing human growth hormone
11/06/1996EP0741188A2 Single chain insulin with high bioactivity
11/06/1996EP0741187A2 Recombinant obese (Ob) proteins
11/06/1996EP0741144A1 Antiannexin-v monoclonal antibody, process for producing the same, and use therof
11/06/1996EP0741141A2 Method of purifying ologonucleotide from biological samples
11/06/1996EP0740708A1 Design of drugs involving receptor-ligand-dna interactions
11/06/1996EP0740707A1 Secretion of proteins from the outer membrane of gram-negative bacteria by gram-positive host organisms
11/06/1996EP0740706A1 Production of acariogenic sugar substitutes
11/06/1996EP0740705A1 THERMOSTABLE VARIANTS OF NEUTRAL PROTEASES OF $i(BACILLUS STEAROTHERMOPHILUS) AND $i(BACILLUS THERMOPROTEOLYTICUS)
11/06/1996EP0740704A1 Immunization by inoculation of dna transcription unit
11/06/1996EP0740703A1 Diagnosis and treatment of infections due to streptococci and enterococci
11/06/1996EP0740702A1 Novel human amyloid protein precursor homologue and kunitz-type inhibitors
11/06/1996EP0740701A1 Mammalian monocyte chemoattractant protein receptors
11/06/1996EP0740700A1 Natural resistance associated macrophage protein and uses thereof
1 ... 3672 3673 3674 3675 3676 3677 3678 3679 3680 3681 3682 3683 3684 3685 3686 3687 3688 3689 3690 3691 3692 ... 4023